Significant decrease in prevalence of Helicobacter pylori in the Czech Republic
Language English Country United States Media print
Document type Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't
PubMed
22969207
PubMed Central
PMC3436059
DOI
10.3748/wjg.v18.i32.4412
Knihovny.cz E-resources
- Keywords
- 13C-urea breath test, Czech Republic, Decline of prevalence, Epidemiology, Helicobacter pylori,
- MeSH
- Breath Tests MeSH
- Child MeSH
- Adult MeSH
- Helicobacter pylori * MeSH
- Helicobacter Infections epidemiology ethnology MeSH
- Middle Aged MeSH
- Humans MeSH
- Longitudinal Studies MeSH
- Adolescent MeSH
- Young Adult MeSH
- Child, Preschool MeSH
- Prevalence MeSH
- Prospective Studies MeSH
- Surveys and Questionnaires MeSH
- Retrospective Studies MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Social Class MeSH
- Check Tag
- Child MeSH
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Adolescent MeSH
- Young Adult MeSH
- Male MeSH
- Child, Preschool MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Multicenter Study MeSH
- Research Support, Non-U.S. Gov't MeSH
- Geographicals
- Czech Republic epidemiology MeSH
AIM: To study possible decrease in prevalence of Helicobacter pylori (H. pylori) infection in the Czech Republic within a 10-year period. METHODS: A total of 22 centres entered the study. The catchment areas of these centres covered cities and towns with more than 20,000 inhabitants, smaller towns (≤ 20,000 inhabitants) with surrounding villages and rural areas, and were spread over the whole country, corresponding well to the geographical distribution of the Czech population. A total of 1,837 subjects (aged 5-98 years) took part in the study, randomly selected out of 38,147 people from the general population. H. pylori infection was investigated by means of a (13)C-urea breath test. Breath samples in duplicates were analysed using isotope ratio mass spectrometry. The cut-off point was 3.5. Social and demographic characteristics were based on data from self-completed questionnaires. RESULTS: The overall prevalence of H. pylori infection was 23.5% (430/1826), and 4.8% (20/420) in children aged 15 or less. There was no statistically significant difference in prevalence between males (24.3%; 208/857) and females (22.9%, 222/969, P = 0.494). H. pylori infection was strongly associated with higher age, among subjects aged 55+ years, prevalence of H. pylori infection was 39.8% (252/633, P < 0.001). The highest prevalence of H. pylori infection was found among persons aged 55-64 years (43.9%, 97/221) and 75+ years (37.9%, 58/153). Among study subjects aged 15+ years, prevalence of H. pylori infection was significantly increased in those with lowest education (odds risk 3.19, 95% CI 1.87-5.47). Compared to never married (14.1%), the prevalence of H. pylori infection was statistically significantly higher among married (35.4%, 246/694, P < 0.001), divorced (36.8%, 49/133, P < 0.001) and widowed study subjects (40.2%, 45/112, P < 0.001), both in minimally and fully adjusted analysis. There was no significant difference in the prevalence of H. pylori infection between married and widowed subjects (35.4%, 246/694 vs 40.2%, 45/112, P = 0.389). There was little variation in smoking prevalence across categories of smoking and there was no evidence of an increased risk of H. pylori infection among current or past smokers in our data (odds risk 1.04 with 95% CI 0.78-1.40 for current smokers; odds ratio 0.83 with 95% CI 0.60-1.16 for former smokers). The current prevalence of H. pylori in 2011 was significantly lower compared to the prevalence reported from identical geographical areas in 2001 (23.5% vs 41.7%, P < 0.001). CONCLUSION: The overall prevalence of H. pylori infection in the general population has fallen substantially in the Czech Republic over the past 10 years.
See more in PubMed
Mahadeva S, Goh KL. Epidemiology of functional dyspepsia: a global perspective. World J Gastroenterol. 2006;12:2661–2666. PubMed PMC
Malaty HM. Epidemiology of Helicobacter pylori infection. Best Pract Res Clin Gastroenterol. 2007;21:205–214. PubMed
Bruce MG, Maaroos HI. Epidemiology of Helicobacter pylori infection. Helicobacter. 2008;13 Suppl 1:1–6. PubMed
Azevedo NF, Huntington J, Goodman KJ. The epidemiology of Helicobacter pylori and public health implications. Helicobacter. 2009;14 Suppl 1:1–7. PubMed
Ford AC, Axon AT. Epidemiology of Helicobacter pylori infection and public health implications. Helicobacter. 2010;15 Suppl 1:1–6. PubMed
Goh KL, Chan WK, Shiota S, Yamaoka Y. Epidemiology of Helicobacter pylori infection and public health implications. Helicobacter. 2011;16 Suppl 1:1–9. PubMed PMC
Mandeville KL, Krabshuis J, Ladep NG, Mulder CJ, Quigley EM, Khan SA. Gastroenterology in developing countries: issues and advances. World J Gastroenterol. 2009;15:2839–2854. PubMed PMC
Crowe SE. Bacteriology and epidemiology of Helicobacter pylori infection. Feldman M, Grover S, editors. 2012. Available from: http://www.uptodate.com/contents/bacteriology-and-epidemiology-of-helicobacter-pylori-infection.
Bures J, Kopácová M, Koupil I, Vorísek V, Rejchrt S, Beránek M, Seifert B, Pozler O, Zivný P, Douda T, et al. Epidemiology of Helicobacter pylori infection in the Czech Republic. Helicobacter. 2006;11:56–65. PubMed
Kopácová M, Bures J, Koupil I, Rejchrt S, Vorísek V, Seifert B, Pozler O, Zivný P, Douda T, Palicka V, et al. Body indices and basic vital signs in Helicobacter pylori positive and negative persons. Eur J Epidemiol. 2007;22:67–75. PubMed PMC
Rejchrt S, Koupil I, Kopácová M, Vorísek V, Seifert B, Pozler O, Zivný P, Douda T, Palicka V, Holcík J, et al. Prevalence and sociodemographic determinants of uninvestigated dyspepsia in the Czech Republic. Eur J Gastroenterol Hepatol. 2008;20:898–905. PubMed
Kopácová M, Bures J, Vorísek V, Konstacký M, Rejchrt S, Zivný P, Douda T, Palicka V. Comparison of different protocols for 13C-urea breath test for the diagnosis of Helicobacter pylori infection in healthy volunteers. Scand J Clin Lab Invest. 2005;65:491–498. PubMed
World Health Organisation Regional Office for Europe. European Mortality database (MDB)
Sterzl I, Hrdá P, Matucha P, Cerovská J, Zamrazil V. Anti-Helicobacter Pylori, anti-thyroid peroxidase, anti-thyroglobulin and anti-gastric parietal cells antibodies in Czech population. Physiol Res. 2008;57 Suppl 1:S135–S141. PubMed
Fixa B, Komárková O, Nozicka Z. Changing prevalence of some selected gastrointestinal diseases vis-à-vis H. pylori infection. Hepatogastroenterology. 2011;58:1062–1066. PubMed
Oona M, Utt M, Nilsson I, Uibo O, Vorobjova T, Maaroos HI. Helicobacter pylori infection in children in Estonia: decreasing seroprevalence during the 11-year period of profound socioeconomic changes. Helicobacter. 2004;9:233–241. PubMed
Jurgos L. Infekce baktérií Helicobacter pylori a funkční dyspepsie - argumenty pro a proti. Postgrad Med (Prague) 2003;5:530–534.
Kuzela L, Oltman M, Sutka J, Zacharova B, Nagy M. Epidemiology of Helicobacter pylori infection in the Slovak Republic. Hepatogastroenterology. 2012;59:754–756. PubMed
Tkachenko MA, Zhannat NZ, Erman LV, Blashenkova EL, Isachenko SV, Isachenko OB, Graham DY, Malaty HM. Dramatic changes in the prevalence of Helicobacter pylori infection during childhood: a 10-year follow-up study in Russia. J Pediatr Gastroenterol Nutr. 2007;45:428–432. PubMed
Roosendaal R, Kuipers EJ, Buitenwerf J, van Uffelen C, Meuwissen SG, van Kamp GJ, Vandenbroucke-Grauls CM. Helicobacter pylori and the birth cohort effect: evidence of a continuous decrease of infection rates in childhood. Am J Gastroenterol. 1997;92:1480–1482. PubMed
Loffeld RJ, van der Putten AB. Changes in prevalence of Helicobacter pylori infection in two groups of patients undergoing endoscopy and living in the same region in the Netherlands. Scand J Gastroenterol. 2003;38:938–941. PubMed
Arents NL, Thijs JC, van Zwet AA, Kleibeuker JH. Does the declining prevalence of Helicobacter pylori unmask patients with idiopathic peptic ulcer disease? Trends over an 8 year period. Eur J Gastroenterol Hepatol. 2004;16:779–783. PubMed
Kosunen TU, Aromaa A, Knekt P, Salomaa A, Rautelin H, Lohi P, Heinonen OP. Helicobacter antibodies in 1973 and 1994 in the adult population of Vammala, Finland. Epidemiol Infect. 1997;119:29–34. PubMed PMC
Rehnberg-Laiho L, Salomaa A, Rautelin H, Koskela P, Sarna S, Kosunen TU. Accelerated decline in Helicobacter pylori seroprevalence rate during the screen and treat project in Vammala, Finland, as demonstrated in 29- to 45-year-old pregnant women. APMIS. 2004;112:34–38. PubMed
Harvey RF, Spence RW, Lane JA, Nair P, Murray LJ, Harvey IM, Donovan J. Relationship between the birth cohort pattern of Helicobacter pylori infection and the epidemiology of duodenal ulcer. QJM. 2002;95:519–525. PubMed
Vyse AJ, Gay NJ, Hesketh LM, Andrews NJ, Marshall B, Thomas HI, Morgan-Capner P, Miller E. The burden of Helicobacter pylori infection in England and Wales. Epidemiol Infect. 2002;128:411–417. PubMed PMC
Rothenbacher D, Schultze V, Jähnig P, Scharschmidt B, Brenner H. Evidence of a rapid decrease in prevalence of Helicobacter pylori infection in children of a high risk group living in Germany. Eur J Pediatr. 2004;163:339–340. PubMed
Asfeldt AM, Steigen SE, Løchen ML, Straume B, Johnsen R, Bernersen B, Florholmen J, Paulssen EJ. The natural course of Helicobacter pylori infection on endoscopic findings in a population during 17 years of follow-up: the Sørreisa gastrointestinal disorder study. Eur J Epidemiol. 2009;24:649–658. PubMed
Dahlerup S, Andersen RC, Nielsen BS, Schjødt I, Christensen LA, Gerdes LU, Dahlerup JF. First-time urea breath tests performed at home by 36,629 patients: a study of Helicobacter pylori prevalence in primary care. Helicobacter. 2011;16:468–474. PubMed
Granström M, Tindberg Y, Blennow M. Seroepidemiology of Helicobacter pylori infection in a cohort of children monitored from 6 months to 11 years of age. J Clin Microbiol. 1997;35:468–470. PubMed PMC
Rautelin H, Kosunen TU. Helicobacter pylori infection in Finland. Ann Med. 2004;36:82–88. PubMed
Salomaa-Räsänen A, Kosunen TU, Aromaa AR, Knekt P, Sarna S, Rautelin H. A “screen-and-treat” approach for Helicobacter pylori infection: a population-based study in Vammala, Finland. Helicobacter. 2010;15:28–37. PubMed
Prónai L, Schandl L, Orosz Z, Magyar P, Tulassay Z. Lower prevalence of Helicobacter pylori infection in patients with inflammatory bowel disease but not with chronic obstructive pulmonary disease - antibiotic use in the history does not play a significant role. Helicobacter. 2004;9:278–283. PubMed
Guslandi M, Fanti L, Testoni PA. Helicobacter pylori seroprevalence in Crohn’s disease: lack of influence by pharmacological treatment. Hepatogastroenterology. 2002;49:1296–1297. PubMed
Kopacova M, Bures J, Koupilova I, Vorisek V, Seifert B, Pozler O, Rejchrt S, Jancova E, Hanka V, Ponizil M, et al. Prevalence of Helicobacter pylori infection in non-selected general population in Czech republic. No birth-cohort phenomenon found in multicentre prospective study. Gut. 2002;51 Suppl 3:A108.
Bardhan PK. Epidemiological features of Helicobacter pylori infection in developing countries. Clin Infect Dis. 1997;25:973–978. PubMed
Brown LM. Helicobacter pylori: epidemiology and routes of transmission. Epidemiol Rev. 2000;22:283–297. PubMed
Graham DY, Malaty HM, Evans DG, Evans DJ, Klein PD, Adam E. Epidemiology of Helicobacter pylori in an asymptomatic population in the United States. Effect of age, race, and socioeconomic status. Gastroenterology. 1991;100:1495–1501. PubMed
Malaty HM, Graham DY. Importance of childhood socioeconomic status on the current prevalence of Helicobacter pylori infection. Gut. 1994;35:742–745. PubMed PMC
O’Connor H, Sebastian S. The burden of Helicobacter pylori infection in Europe. Aliment Pharmacol Ther. 2003;18 Suppl 3:38–44. PubMed
Sipponen P. Helicobacter pylori: a cohort phenomenon. Am J Surg Pathol. 1995;19 Suppl 1:S30–S36. PubMed
den Hoed CM, Vila AJ, Holster IL, Perez-Perez GI, Blaser MJ, de Jongste JC, Kuipers EJ. Helicobacter pylori and the birth cohort effect: evidence for stabilized colonization rates in childhood. Helicobacter. 2011;16:405–409. PubMed PMC
Manuel D, Cutler A, Goldstein J, Fennerty MB, Brown K. Decreasing prevalence combined with increasing eradication of Helicobacter pylori infection in the United States has not resulted in fewer hospital admissions for peptic ulcer disease-related complications. Aliment Pharmacol Ther. 2007;25:1423–1427. PubMed
McJunkin B, Sissoko M, Levien J, Upchurch J, Ahmed A. Dramatic decline in prevalence of Helicobacter pylori and peptic ulcer disease in an endoscopy-referral population. Am J Med. 2011;124:260–264. PubMed
Xia B, Xia HH, Ma CW, Wong KW, Fung FM, Hui CK, Chan CK, Chan AO, Lai KC, Yuen MF, et al. Trends in the prevalence of peptic ulcer disease and Helicobacter pylori infection in family physician-referred uninvestigated dyspeptic patients in Hong Kong. Aliment Pharmacol Ther. 2005;22:243–249. PubMed
Chen J, Bu XL, Wang QY, Hu PJ, Chen MH. Decreasing seroprevalence of Helicobacter pylori infection during 1993-2003 in Guangzhou, southern China. Helicobacter. 2007;12:164–169. PubMed
Nakajima S, Nishiyama Y, Yamaoka M, Yasuoka T, Cho E. Changes in the prevalence of Helicobacter pylori infection and gastrointestinal diseases in the past 17 years. J Gastroenterol Hepatol. 2010;25 Suppl 1:S99–S110. PubMed
Lee SY, Park HS, Yu SK, Sung IK, Jin CJ, Choe WH, Kwon SY, Lee CH, Choi KW. Decreasing prevalence of Helicobacter pylori infection: a 9-year observational study. Hepatogastroenterology. 2007;54:630–633. PubMed
Ho KY, Chan YH, Kang JY. Increasing trend of reflux esophagitis and decreasing trend of Helicobacter pylori infection in patients from a multiethnic Asian country. Am J Gastroenterol. 2005;100:1923–1928. PubMed
Zhang DH, Zhou LY, Lin SR, Ding SG, Huang YH, Gu F, Zhang L, Li Y, Cui RL, Meng LM, et al. Recent changes in the prevalence of Helicobacter pylori infection among children and adults in high- or low-incidence regions of gastric cancer in China. Chin Med J (Engl) 2009;122:1759–176. PubMed
Bures J. Worms - friend or foe? The new “Old friends’ hypothesis”. Folia Gastroenterol Hepatol. 2009;7:50–53.
Fox JG, Wang TC, Nagler-Anderson C. The African enigma: the parasite’s perspective. Gut. 2001;49:156–157. PubMed PMC
Agha A, Graham DY. Evidence-based examination of the African enigma in relation to Helicobacter pylori infection. Scand J Gastroenterol. 2005;40:523–529. PubMed
Graham DY, Lu H, Yamaoka Y. African, Asian or Indian enigma, the East Asian Helicobacter pylori: facts or medical myths. J Dig Dis. 2009;10:77–84. PubMed PMC
Blaser MJ, Chen Y, Reibman J. Does Helicobacter pylori protect against asthma and allergy? Gut. 2008;57:561–567. PubMed PMC
Reibman J, Marmor M, Filner J, Fernandez-Beros ME, Rogers L, Perez-Perez GI, Blaser MJ. Asthma is inversely associated with Helicobacter pylori status in an urban population. PLoS One. 2008;3:e4060. PubMed PMC
Blaser MJ. Equilibria of humans and our indigenous microbiota affecting asthma. Proc Am Thorac Soc. 2012;9:69–71. PubMed PMC
Holster IL, Vila AM, Caudri D, den Hoed CM, Perez-Perez GI, Blaser MJ, de Jongste JC, Kuipers EJ. The impact of Helicobacter pylori on atopic disorders in childhood. Helicobacter. 2012;17:232–237. PubMed PMC
Sonnenberg A, Genta RM. Low prevalence of Helicobacter pylori infection among patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2012;35:469–476. PubMed
Sýkora J, Siala K, Varvarovská J, Pazdiora P, Pomahacová R, Huml M. Epidemiology of Helicobacter pylori infection in asymptomatic children: a prospective population-based study from the Czech Republic. Application of a monoclonal-based antigen-in-stool enzyme immunoassay. Helicobacter. 2009;14:286–297. PubMed
Bateson MC. Cigarette smoking and Helicobacter pylori infection. Postgrad Med J. 1993;69:41–44. PubMed PMC
Brenner H, Rothenbacher D, Bode G, Adler G. Relation of smoking and alcohol and coffee consumption to active Helicobacter pylori infection: cross sectional study. BMJ. 1997;315:1489–1492. PubMed PMC
Ozden A, Bozdayi G, Ozkan M, Köse KS. Changes in the seroepidemiological pattern of Helicobacter pylori infection over the last 10 years. Turk J Gastroenterol. 2004;15:156–158. PubMed
Kawakami E, Machado RS, Ogata SK, Langner M. Decrease in prevalence of Helicobacter pylori infection during a 10-year period in Brazilian children. Arq Gastroenterol. 2008;45:147–151. PubMed
Sýkora J, Rowland M. Helicobacter pylori in pediatrics. Helicobacter. 2011;16 Suppl 1:59–64. PubMed
Blaser MJ. Hypothesis: the changing relationships of Helicobacter pylori and humans: implications for health and disease. J Infect Dis. 1999;179:1523–1530. PubMed
Blaser MJ. Who are we? Indigenous microbes and the ecology of human diseases. EMBO Rep. 2006;7:956–960. PubMed PMC
Blaser MJ. Disappearing microbiota: Helicobacter pylori protection against esophageal adenocarcinoma. Cancer Prev Res (Phila) 2008;1:308–311. PubMed
Atherton JC, Blaser MJ. Coadaptation of Helicobacter pylori and humans: ancient history, modern implications. J Clin Invest. 2009;119:2475–2487. PubMed PMC
Cover TL, Blaser MJ. Helicobacter pylori in health and disease. Gastroenterology. 2009;136:1863–1873. PubMed PMC
Blaser MJ. Helicobacter pylori and esophageal disease: wake-up call? Gastroenterology. 2010;139:1819–1822. PubMed PMC
Blaser MJ. Heterogeneity of Helicobacter pylori. Eur J Gastroenterol Hepatol. 2012;9 Suppl 1:S3–6; discussion S6-7. PubMed